跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUWIQ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NUWIQ
Authorized
STANDARD
NUWIQ
octapharma pharmazeutika produktionsges m b h
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2e8806bb857e2377
Company
octapharma pharmazeutika produktionsges m b h
Type
Standard
Approval Details
Approval Id
2e8806bb857e2377
Drug Approval Canada Name
NUWIQ
Product Name
NUWIQ
Status
Dormant
Status Date
2023-07-31
Original Market Date
2018-07-25
Din
02474069
Drug Class
Human
Dosage Form
Powder For Solution , Kit
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BD02 COAGULATION FACTOR VIII
Atc Name
b 02 bd 02
Aig Number
0256190007
Company Name
octapharma pharmazeutika produktionsges m b h
Company Address
Oberlaaer Strasse 235, Vienna, Vienne, Austria, 1100
Active Ingredients
SIMOCTOCOG ALFA
4000 UNIT / VIAL
WATER
2.5 ML / SYR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2e8806bb857e2377
Type
Standard
Back to Health Canada Approvals